argenX SE Files Form 6-K with SEC
Ticker: ARGX · Form: 6-K · Filed: Jun 20, 2025 · CIK: 1697862
Sentiment: neutral
Topics: sec-filing, foreign-private-issuer, regulatory-update
TL;DR
argenX SE dropped a 6-K filing on 6/20/25, check it for updates.
AI Summary
On June 20, 2025, argenx SE announced the issuance of a press release. The filing is a Form 6-K, which is a report of a foreign private issuer submitted to the SEC. The company is incorporated in P7 and its fiscal year ends on December 31.
Why It Matters
This filing indicates that argenX SE is providing updated information to the SEC, which could include material developments relevant to investors.
Risk Assessment
Risk Level: low — This filing is a routine submission of a foreign private issuer and does not appear to contain significant new financial or operational information.
Key Numbers
- 001-38097 — SEC File Number (Identifies the specific filing with the SEC.)
Key Players & Entities
- argenx SE (company) — Registrant
- 001-38097 (company) — SEC File Number
- 20250620 (date) — Filing Date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to submit information that the company may be required to disclose or make public in its home country.
When was this Form 6-K filed?
This Form 6-K was filed on June 20, 2025.
What is the principal executive office address of argenx SE?
The principal executive offices are located at Laarderhoogtweg 25, 1101 EB Amsterdam, the Netherlands.
What is the SIC code for argenx SE?
The Standard Industrial Classification (SIC) code for argenx SE is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Does argenx SE file annual reports under Form 20-F or 40-F?
argenx SE indicates it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 20, 2025 regarding ARGENX SE (ARGX).